HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neural cell adhesion molecule and prognosis of surgically resected lung cancer.

Abstract
The prognostic significance of the expression of neural cell adhesion molecule (NCAM), a neuroendocrine antigen in lung cancer, was analyzed by an indirect immunoperoxidase method in 97 surgically treated patients. Reactivity of MOC-1 and S-L 11.14, both cluster-1 monoclonal antibodies directed against NCAM, was positive in all nine small-cell lung cancers and in 16 of 88 (18%) non-small-cell lung cancers. For the latter group, this expression demonstrated a phenotypic heterogeneity that was mainly observed in poorly differentiated squamous cell carcinomas and in stage N2 non-small-cell lung cancers. Patients with NCAM-positive non-small-cell lung cancer proved to have a shorter survival than those with NCAM-negative disease. In Cox's model for multivariate analysis, nodal status and histology were the main independent determinants of prognosis. We therefore concluded that NCAM expression in non-small-cell lung cancer is correlated to nodal status and that it indicates a poor prognosis. These findings confirm that the diversification of lung cancer phenotype leads to tumor progression and brings a negative prognosis to surgically resected non-small-cell lung cancer. However, nodal status remains the most important prognostic variable, suggesting that NCAM expression is only one of numerous biological events that promote tumor progression.
AuthorsJ L Pujol, J Simony, P Demoly, R Charpentier, J C Laurent, J P Daurès, M Lehmann, V Guyot, P Godard, F B Michel
JournalThe American review of respiratory disease (Am Rev Respir Dis) Vol. 148 Issue 4 Pt 1 Pg. 1071-5 (Oct 1993) ISSN: 0003-0805 [Print] United States
PMID8214927 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Adhesion Molecules, Neuronal
Topics
  • Adenocarcinoma (metabolism, mortality, pathology, surgery)
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Large Cell (metabolism, mortality, pathology, surgery)
  • Carcinoma, Small Cell (metabolism, mortality, pathology, surgery)
  • Carcinoma, Squamous Cell (metabolism, mortality, pathology, surgery)
  • Cell Adhesion Molecules, Neuronal (metabolism)
  • Female
  • France (epidemiology)
  • Humans
  • Immunoenzyme Techniques
  • Immunohistochemistry
  • Lung Neoplasms (metabolism, mortality, pathology, surgery)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Phenotype
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: